PATENT CLAIM ANALYSIS

Application Number: 16248912
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or disorders using the TNFα antisense oligonucleotides and related products are provided.

Claim (Index 88):
The method of  claim 73 , wherein the antisense oligonucleotide is 18 nucleotides in length and is selected from the group consisting of T-G-G-G-A-G-T-A-G-A-T-G-A-G-G-T-A-C (SEQ ID NO. 4), mUmGmGmGmAmGmUmAmGmAmUmGmAmGmGmUmAmC (SEQ ID NO. 10, Oligo 3742), T*G*G*G*A*G*T*A*G*A*T*G*A*G*G*T*A*C (SEQ ID NO. 9, Oligo 3500), mUmGmGmGmAmGT*A*G*A*T*G*mAmGmGmUmAmC (SEQ ID NO. 16, Oligo 3534), and mU*mG*mG*mG*mA*mG*T*A*G*A*T*G*mA*mG*mG*mU*mA*mC (SEQ ID NO. 18, Oligo 3509) wherein\u2014refers to a phosphodiester bond, * refers to a phosphorothioate bond, and m refers to a O methyl.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15517064', '10644052', '14114471', '11748422', '12952863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7924896968045048
- 35 USC 102 Novelty (BERT): 0.6042388756151361
- Combined Prediction Score: 0.7736646146855679
- Mean Citation Score: 328.277526
- Max Citation Score: 593.3532
- Similarity Product: 437.7235788937569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test